Zynex Inc, a medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management and stroke rehabilitation as well as neurological diagnostics and compound pharmacy, has announced the appointment of Brian Alleman as its new chief financial officer (CFO). A news release from Zynex Inc, notes that Alleman has over 25 years experience serving both public and private companies, most recently serving as managing director at Alleman & Associates, a strategic business advisory firm.
According to the Zynex news release, Alleman has served on five public company boards throughout his career and has years of experience assisting companies with corporate turnarounds, capital raising, strategic planning, business development, finance, investor relations, and other strategic business issues.
Thomas Sandgaard, CEO of Zynex, states, “We are very excited to welcome Brian Alleman as our new chief financial officer at Zynex. Mr Alleman is a seasoned professional, with a successful track record assisting emerging growth companies, and providing leadership during transitional periods.”
Sandgaard adds, “We believe Brian will be a great asset for us as we re-position our company for growth.”
The Zynex news release indicates that Anthony Scalese, serving CFO of Zynex, resigned effective July 6, 2014. Scalese continues to provide transition services to the company as needed on a consulting basis following his departure.
Zynex Inc, operates under five primary business segments: Zynex Medical, NeuroDiagnostics, Monitoring Solutions, International, and Billing and Consulting. The company news release reports that Zynex Medical engineers, manufactures, markets, and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. The company’s proprietary NeuroMove device is designed to help recovery of stroke and spinal cord injury patients.
[Source: Zynex Inc]